# Milestone Pharmaceuticals Posts $2.96 Million in Q3 Revenue, Beating Estimate

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56630
Published: 2026-11-13T12:25:12.000Z
Updated: 2026-11-13T12:25:12.000Z
Section: Business

> Its GAAP loss per share was $0.18, 4 cents smaller than estimated.

Milestone Pharmaceuticals posted $2.96 million in third-quarter revenue, exceeding the estimate by $1.96 million, while its per-share loss was smaller than estimated.

GAAP earnings per share showed a loss of $0.18, 4 cents smaller than estimated.